Recombinant erythroid differentiation regulator 1 inhibits both inflammation and angiogenesis in a mouse model of rosacea

Experimental Dermatology

Volumn 24, Issue 9, 2015, Pages 680-685

  Kim, Miri ^a   Kim, Kyung Eun ^b   Jung, Haw Young ^a   Jo, Hyunmu ^a   Jeong, Seo Won ^a   Lee, Jahyung ^c   Kim, Chang Han ^d   Kim, Heejong ^d   Cho, Daeho ^b   Park, Hyun Jeong ^a  

^a The Catholic University of Korea   (South Korea)

^b Sookmyung Women's University   (South Korea)

^c Mercersburg Academy   (United States)

^d NeoRegen Biotech Co   (South Korea)

Author keywords

Angiogenesis; Erdr1; IL 18; Inflammation; Rosacea

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 18; RECOMBINANT ERYTHROID DIFFERENTIATION REGULATOR 1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; ERYTHROID DIFFERENTIATION REGULATOR 1, MOUSE; MEMBRANE PROTEIN; TUMOR SUPPRESSOR PROTEIN; VASCULOTROPIN A;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CAPILLARY DENSITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ERYTHEMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATORY INFILTRATE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; ROSACEA; TELANGIECTASIA; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; DISEASE MODEL; DRUG EFFECTS; INFLAMMATION; METABOLISM; MICROVASCULATURE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; YOUNG ADULT;

ADULT; AGED; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ERYTHEMA; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-18; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RECOMBINANT PROTEINS; ROSACEA; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84939190152     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12745     Document Type: Article

References (53)

1. Steinhoff M, Buddenkotte J, Aubert J et al. J Investig Dermatol Symp Proc 2011: 15: 2-11.
2. Lindow K B, Warren C. Am J Nurs 2001: 101: 44-51; quiz 52.
3. Steinhoff M, Schauber J, Leyden J J. J Am Acad Dermatol 2013: 69: S15-S26.
4. Yamasaki K, Gallo R L. J Dermatol Sci 2009: 55: 77-81.
5. Layton A, Thiboutot D. J Am Acad Dermatol 2013: 69: S57-S65.
6. Yamasaki K, Di Nardo A, Bardan A et al. Nat Med 2007: 13: 975-980.
7. Casas C, Paul C, Lahfa M et al. Exp Dermatol 2012: 21: 906-910.
8. Aksoy B, Altaykan-Hapa A, Egemen D et al. Br J Dermatol 2010: 163: 719-725.
9. Scheinfeld N, Berk T. Postgrad Med 2010: 122: 139-143.
10. Alam M, Voravutinon N, Warycha M et al. J Am Acad Dermatol 2013: 69: 438-443.
11. Swanson J K. Dermatol Nurs 2003: 15: 359-362.
12. DiGiovanna J J. Arch Dermatol 2010: 146: 551-553.
13. Gauwerky K, Klovekorn W, Korting H C et al. J Dtsch Dermatol Ges 2009: 7: 996-1003.
14. Okamura H, Tsutsi H, Komatsu T et al. Nature 1995: 378: 88-91.
15. Dinarello C A. J Allergy Clin Immunol 1999: 103: 11-24.
16. Rasmy H, Mikhael N, Ismail S. Arch Med Sci 2011: 7: 713-719.
17. Kou K, Aihara M, Matsunaga T et al. Arch Dermatol Res 2012: 304: 305-312.
18. Wang D, Drenker M, Eiz-Vesper B et al. Arthritis Rheum 2008: 58: 3205-3215.
19. Salamon M, Sysa-Jedrzejowska A, Lukamowicz J et al. Przegl Lek 2008: 65: 371-374.
20. Dormer P, Spitzer E, Frankenberger M et al. Cytokine 2004: 26: 231-242.
21. Lee Y B, Kim H J, Jung H Y et al. Int J Dermatol 2014: 53: 723-730.
22. Dormer P, Spitzer E, Moller W. Cytokine 2004: 27: 47-57.
23. Jung M K, Park Y, Song S B et al. J Invest Dermatol 2011: 131: 2096-2104.
24. Jung M K, Houh Y K, Ha S et al. Immunol Lett 2013: 150: 145-151.
25. Zhang J, Xu X, Rao N V et al. PLoS ONE 2011: 6: e16658.
26. Hirsch F R, Varella-Garcia M, Bunn P A Jr et al. J Clin Oncol 2003: 21: 3798-3807.
27. Koczulla R, von Degenfeld G, Kupatt C et al. J Clin Invest 2003: 111: 1665-1672.
28. Cribier B. J Eur Acad Dermatol Venereol 2013: 27: 1336-1343.
29. Shahneh F Z, Baradaran B, Zamani F et al. Hum Antibodies 2013: 22: 15-19.
30. Gomaa A H, Yaar M, Eyada M M et al. J Cutan Pathol 2007: 34: 748-753.
31. Wittmann M, Purwar R, Hartmann C et al. J Invest Dermatol 2005: 124: 1225-1233.
32. Oztas M O, Balk M, Ogus E et al. Clin Exp Dermatol 2003: 28: 188-192.
33. Kim H J, Song S B, Yang Y et al. Exp Dermatol 2011: 20: 920-925.
34. Kaminska B. Biochim Biophys Acta 2005: 1754: 253-262.
35. Schauber J, Gallo R L. J Invest Dermatol 2007: 127: 510-512.
36. Ricard-Blum S, Salza R. Exp Dermatol 2014: 23: 457-463.
37. Schauber J, Gallo R L. J Allergy Clin Immunol 2009: 124: R13-R18.
38. Schwab V D, Sulk M, Seeliger S et al. J Investig Dermatol Symp Proc 2011: 15: 53-62.
39. Gerber P A, Buhren B A, Steinhoff M et al. J Investig Dermatol Symp Proc 2011: 15: 40-47.
40. de Almeida T F, Romana-Souza B, Machado S et al. Exp Dermatol 2013: 22: 524-529.
41. Brown T T, Choi E Y, Thomas D G et al. J Am Acad Dermatol 2014: 71: 100-107.
42. Georgala S, Katoulis A C, Kylafis G D et al. J Eur Acad Dermatol Venereol 2001: 15: 441-444.
43. Park C C, Morel J C, Amin M A et al. J Immunol 2001: 167: 1644-1653.
44. Smith J R, Lanier V B, Braziel R M et al. Br J Ophthalmol 2007: 91: 226-229.
45. Huggenberger R, Detmar M. J Investig Dermatol Symp Proc 2011: 15: 24-32.
46. Yoo S A, Kwok S K, Kim W U. Mediators Inflamm 2008: 2008: 129873.
47. Yano K, Oura H, Detmar M. J Invest Dermatol 2002: 118: 800-805.
48. Mor F, Quintana F J, Cohen I R. J Immunol 2004: 172: 4618-4623.
49. Aroni K, Tsagroni E, Kavantzas N et al. Arch Dermatol Res 2008: 300: 125-131.
50. Cuevas P, Arrazola J M. Eur J Med Res 2005: 10: 454-456.
51. Kim K E, Song H, Kim T S et al. Oncogene 2007: 26: 1468-1476.
52. Ju D W, Tao Q, Lou G et al. Cancer Res 2001: 61: 3735-3740.
53. Cao R, Farnebo J, Kurimoto M et al. FASEB J 1999: 13: 2195-2202.